BiotechTube
NEURO-ZONE

NEURO-ZONE

Milan, Italy· Est.
neuro-zone.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Neuro-Zone is a private, Milan-based preclinical CRO founded in 2019, built on over 15 years of scientific expertise. The company operates as a high-quality outsourced laboratory, offering customized research projects, proprietary cell phenotyping and ototoxicity screening platforms, and collaborative research partnerships. It serves clients in neuroscience, oncology, and autoimmune disorders, generating revenue through service contracts and grant-funded projects, positioning itself as a specialized partner in the early-stage drug discovery value chain.

NeuroscienceOncologyAutoimmune DisordersOtotoxicity

Technology Platform

A suite of integrated cell-based platforms for preclinical discovery: Cell Phenotyping (flow cytometry/FACS), Ototox (ototoxicity screening), Mitos (mitochondrial toxicity), and Electra (electrophysiology). Combined with customized, pathology-specific in vitro disease models and multiparametric assay services.

Opportunities

Growing demand for specialized, human-relevant preclinical models from biotech and pharma, especially in complex areas like neuroscience.
Participation in EU and other public grant programs provides non-dilutive funding and validates technology.
The niche focus on ototoxicity and integrated BBB models offers differentiation in a crowded CRO market.

Risk Factors

Revenue dependency on cyclical client R&D spending and competitive grant awards.
Intense competition from large global CROs and other niche specialists.
Reliance on a small team of highly specialized scientists, creating key-person risk and potential scalability challenges.

Competitive Landscape

Operates in the competitive preclinical CRO sector, competing against large global players (e.g., Charles River, Eurofins, Evotec) and numerous small specialist labs. Differentiation is based on deep scientific expertise in complex cell models, proprietary platforms like Ototox, and a collaborative, customized service approach rather than high-throughput scale.

More companies in Neuroscience & CNS →More companies in Italy →